These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8641970)

  • 1. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness.
    Hasebe T; Tsuda H; Hirohashi S; Shimosato Y; Iwai M; Imoto S; Mukai K
    Jpn J Cancer Res; 1996 Apr; 87(4):385-94. PubMed ID: 8641970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
    Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
    Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
    Dabbs DJ
    Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological grade in invasive ductal carcinoma of breast correlates with the proliferative activity evaluated by BrdU: an immunohistochemical study including correlations with p53, c-erbB-2 and estrogen receptor status.
    Moriki T; Takahashi T; Hiroi M; Yamane T; Hara H
    Pathol Int; 1996 Jun; 46(6):417-25. PubMed ID: 8869993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast.
    Hasebe T; Imoto S; Ogura T; Mukai K
    Jpn J Cancer Res; 1997 Sep; 88(9):877-85. PubMed ID: 9369936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients.
    Hasebe T; Tsuda H; Hirohashi S; Shimosato Y; Tsubono Y; Yamamoto H; Mukai K
    Breast Cancer Res Treat; 1998 Jun; 49(3):195-208. PubMed ID: 9776503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative activity in breast carcinoma evaluated by BrdU and PCNA. Correlation with expression of p53, c-erbB-2, estrogen receptor and P-glycoprotein.
    Moriki T; Takahashi T; Tanioka F; Yamane T; Hara H
    Pathol Res Pract; 1995 Nov; 191(11):1122-32. PubMed ID: 8822114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Mod Pathol; 2001 Apr; 14(4):325-37. PubMed ID: 11301349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study.
    Hasebe T; Sasaki S; Imoto S; Mukai K; Yokose T; Ochiai A
    Mod Pathol; 2002 May; 15(5):502-16. PubMed ID: 12011255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
    Soslow RA; Carlson DL; Horenstein MG; Osborne MP
    Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus.
    Hasebe T; Mukai K; Tsuda H; Ochiai A
    Pathol Int; 2000 Apr; 50(4):263-72. PubMed ID: 10849311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
    Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R
    Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.
    Umekita Y; Takasaki T; Yoshida H
    Virchows Arch; 1994; 424(5):491-4. PubMed ID: 7913368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
    Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H
    Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast.
    Menezes MV; Cestari AL; Almeida O; Alvarenga M; Pinto GA; Gurgel MS; Souza GA; Zeferino LC
    Sao Paulo Med J; 2006 May; 124(3):121-4. PubMed ID: 17119686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
    Hasebe T; Imoto S; Sasaki S; Mukai K
    Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of carbonic anhydrase IX protein in fibrotic foci of mammary invasive ductal carcinomas].
    Li M; Bao L; Cai H; Yang H; Ge W; Ren L; Lu B
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):250-3. PubMed ID: 25975907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of the proliferating antigen Ki67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma.
    Niewiadomska H; Jeziorski A; Olborski B
    J Exp Clin Cancer Res; 1998 Dec; 17(4):503-10. PubMed ID: 10089075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
    Leal C; Henrique R; Monteiro P; Lopes C; Bento MJ; De Sousa CP; Lopes P; Olson S; Silva MD; Page DL
    Hum Pathol; 2001 May; 32(5):487-93. PubMed ID: 11381366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.